You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

SAMHSA Advisory: Cannabidiol (CBD)-Potential Harms, Side Effects, and Unknowns

Published:
February 27, 2023

SAMHSA has issued a new advisory on “Cannabidiol (CBD) – Potential Harms, Side Effects, and Unknowns”. This advisory introduces readers to cannabidiol (CBD), how it is derived, and how it differs from delta-9 THC and other cannabinoids. The advisory focuses on the risks and harms of CBD, especially those products sold directly to consumers. This advisory also clarifies common misconceptions about CBD, given its broad availability and marketing for several medical conditions despite limited evidence of efficacy. It is critical that the general public be made aware of the potential harms associated with CBD use, and parents should keep these products out of the hands of their children.

 

Link to Article

 

CBD
Author(s)
Substance Abuse and Mental Health Administration (SAMHSA)
Contributing Center(s):
map-markermagnifiercrossmenuchevron-down